Allarity Therapeutics, Inc. (ALLR) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 34.5M | 17.93M | 20.47M | 20.88M | 29.42M | 22.34M | 20.37M | 21.31M | 2.29M | 1.97M | 3.56M | 2.38M |
| Cash & Short-Term Investments | 19.81M | 14.69M | 16.89M | 17.8M | 25.2M | 19.53M | 18.46M | 19.23M | 312K | 166K | 1.4M | 420K |
| Cash Only | 19.81M | 14.69M | 16.89M | 17.8M | 25.2M | 19.53M | 18.46M | 19.23M | 312K | 166K | 1.4M | 420K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.08M | 895K | 1.66M | 1.61M | 1.11M | 2.23M | 1.65M | 1.58M | 1.33M | 946K | 1.63M | 1.6M |
| Days Sales Outstanding | 3.56K | 367.57 | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 13.61M | 2.35M | 113K | 116K | 2.61M | 72K | 100K | 131K | 110K | 78K | 136K | 139K |
| Total Non-Current Assets | 420K | 330K | 330K | 322K | 308K | 309K | 12K | 9.57M | 9.67M | 9.89M | 10.31M | 11.04M |
| Property, Plant & Equipment | 420K | 330K | 330K | 322K | 308K | 309K | 12K | 17K | 18K | 20K | 29K | 26K |
| Fixed Asset Turnover | 0.07x | 0.97x | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.56M | 9.66M | 9.87M | 9.46M | 9.71M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 824K | 1.3M |
| Total Assets | 34.92M | 18.26M | 20.8M | 21.2M | 29.73M | 22.65M | 20.38M | 30.88M | 11.97M | 11.86M | 13.88M | 13.43M |
| Asset Turnover | 0.00x | 0.02x | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 17.47% | -19.39% | 2.05% | -31.34% | 148.39% | 90.95% | 46.87% | 130.02% | -5.77% | -18.44% | -23.49% | -42.21% |
| Total Current Liabilities | 28M | 8.43M | 8.79M | 9.04M | 11.06M | 10.84M | 7.41M | 10.62M | 18.01M | 14.17M | 15.74M | 12.67M |
| Accounts Payable | 4.24M | 4.28M | 4.6M | 4.61M | 4.35M | 4.18M | 4.69M | 7.75M | 11.06M | 8.42M | 6.35M | 8.09M |
| Days Payables Outstanding | -14.74K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 21.5M | 1.4M | 1.39M | 1.38M | 1.36M | 1.35M | 1.34M | 1.32M | 2.69M | 1.3M | 0 | 350K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43K | 0 | 0 | 0 |
| Other Current Liabilities | 2.19M | 0 | 2.67M | 0 | 0 | 1K | 2K | 1.18M | 3.82M | 3.99M | 9.21M | 4.02M |
| Current Ratio | 1.23x | 2.13x | 2.33x | 2.31x | 2.66x | 2.06x | 2.75x | 2.01x | 0.13x | 0.14x | 0.23x | 0.19x |
| Quick Ratio | 1.23x | 2.13x | 2.33x | 2.31x | 2.66x | 2.06x | 2.75x | 2.01x | 0.13x | 0.14x | 0.23x | 0.19x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 432K | 432K | 446K | 1.51M | 1.48M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.17M | 1.14M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 432K | 432K | 446K | 343K | 343K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 28M | 8.43M | 8.79M | 9.04M | 11.06M | 10.84M | 7.41M | 11.05M | 18.44M | 14.61M | 17.25M | 14.15M |
| Total Debt | 21.5M | 1.4M | 1.39M | 1.38M | 1.36M | 1.35M | 1.34M | 1.32M | 2.69M | 1.3M | 1.17M | 1.49M |
| Net Debt | 1.68M | -13.29M | -15.51M | -16.43M | -23.84M | -18.18M | -17.13M | -17.91M | 2.38M | 1.13M | -232K | 1.07M |
| Debt / Equity | 3.11x | 0.14x | 0.12x | 0.11x | 0.07x | 0.11x | 0.10x | 0.07x | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -11.74x | -56.17x | -48.23x | -192.33x | -46.93x | -98.37x | -238.34x | -2.82x | -36.72x | -6.13x | -129.79x | -15.76x |
| Total Equity | 6.92M | 9.83M | 12.01M | 12.17M | 18.67M | 11.81M | 12.96M | 19.84M | -6.47M | -2.75M | -3.38M | -723K |
| Equity Growth % | -62.93% | -16.79% | -7.35% | -38.66% | 388.5% | 529.33% | 483.66% | 2843.43% | -1808.85% | -245.56% | -196.46% | -107.17% |
| Book Value per Share | 0.43 | 0.68 | 0.81 | 0.78 | 1.67 | 1.62 | 8.23 | 39.73 | -33.23 | -0.28 | -0.82 | -1.16 |
| Total Shareholders' Equity | 6.92M | 9.83M | 12.01M | 12.17M | 18.67M | 11.81M | 12.96M | 19.84M | -6.47M | -2.75M | -3.38M | -723K |
| Common Stock | 3K | 3K | 3K | 2K | 2K | 1K | 0 | 3K | 0 | 0 | 0 | 0 |
| Retained Earnings | -132.95M | -130.2M | -126.82M | -124.02M | -121.7M | -118.97M | -111.51M | -99.92M | -98.29M | -94.45M | -92.73M | -88.28M |
| Treasury Stock | -3.45M | -3.19M | -2.71M | -2.56M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.08M | -1.02M | -2.3M | -2.46M | -630K | -354K | -693K | -530K | -386K | -411K | -758K | -666K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |